NON SMALL CELL LUNG CARCINOMA
Clinical trials for NON SMALL CELL LUNG CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG CARCINOMA trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Breathing in a new hope: inhaled drug trial aims to boost lung cancer treatment
Disease control Not yet recruitingThis study is testing if adding an inhaled drug called azacytidine to standard pre-surgery treatment can better fight early-stage lung cancer. The inhaled drug is designed to target the lungs directly with fewer side effects. About 60 adults with operable lung cancer will receive…
Matched conditions: NON SMALL CELL LUNG CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New pill targets Tough-to-Treat lung cancer mutation
Disease control Not yet recruitingThis study is testing a new oral medication called BPI-361175 for adults with advanced non-small cell lung cancer (NSCLC) that has a specific genetic change called an EGFR mutation, including a hard-to-treat type known as C797S. The main goals are to find a safe and effective dos…
Matched conditions: NON SMALL CELL LUNG CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Xcovery Holdings, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC